Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Thermo Fisher Scientific Inc. is a global life sciences company offering analytical instruments, laboratory products, biopharmaceutical services, and specialty diagnostics. Shares rose on...
— Neal Kaufman
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Thermo Fisher Scientific Inc.
Thermo Fisher Scientific ($TMO) operates as the quintessential supplier of laboratory instruments, consumables, reagents, and services essential to life sciences research and drug commercialization. Representing 7.18% of...
Thermo Fisher functions as a leading end-to-end platform in the life sciences sector with exceptional scale and reliable performance. The manager leveraged...
More institutional theses from Baron Health Care Fund
Eli Lilly and Company ($LLY) is a global pharmaceutical leader specializing in treatments for diabetes, obesity, oncology, and immunology, representing the Fund's largest portfolio holding at 14.3% of net assets. The manager maintains...
Xenon Pharmaceuticals Inc. ($XENE) is a clinical-stage biopharmaceutical developer focused on novel ion channel therapies for neurological disorders. The manager adopted...
Mettler-Toledo International Inc. ($MTD) manufactures precision laboratory balances, analytical instruments, and industrial inspection systems essential for research and quality assurance, comprising 7.5% of fund assets. The manager holds...